SAN FRANCISCO--(BUSINESS WIRE)--Rune Labs, a leader in precision medicine for Parkinson’s Disease (PD), today previewed the results of an ongoing nine-month research program involving a diverse cohort ...
Title: A Randomized, Double Blind, Placebo-Controlled Study with UB-312, an Anti-Alpha-Synuclein Peptide Vaccine in Parkinson’s Disease Patients Vaxxinity, Inc. is a purpose-driven biotechnology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback